Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
XARELTO 1 mg/ml GRANULADO PARA SUSPENSION ORAL
Suspension
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- RIVAROXABAN — 1 mg
- Pharmaceutical form Home Med Cabinet grouping
- Suspension
- Availability in Spain
- All 2 packs marketed
Packs
XARELTO 1 mg/ml GRANULADO PARA SUSPENSION ORAL, 1 frasco de 2,625 g de granulado
2.625 g
National code
Marketed730290Strength of this pack 1 mg
XARELTO 1 mg/ml GRANULADO PARA SUSPENSION ORAL, 1 frasco de 5,25 g de granulado
5.25 g
National code
Marketed730292Strength of this pack 1 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 108472050Official data
- Marketing authorisation holder
- BAYER AGOfficial data
- Authorised
- Feb 9, 2021Official data
- Authority form code
- 11Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.